Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year

References

• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2016;66(4):271–289.
   PubMed Web of Science ®Google Scholar
• Klemp JR, Myers JS, Fabian CJ, et al. Cognitive functioning and quality of life following chemotherapy in pre- and peri-menopausal women with breast cancer. Support Care Cancer. 2018;26(2):575–583.
   PubMed Web of Science ®Google Scholar
• Conroy SK, McDonald BC, Smith DJ, et al. Alterations in brain structure and function in breast cancer survivors: effect of post-chemotherapy interval and relation to oxidative DNA damage. Breast Cancer Res Treat. 2013;137(2):493–502.
   PubMed Web of Science ®Google Scholar
• Pomykala KL, Ganz PA, Bower JE, et al. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav. 2013;7(4):511–523.
   PubMed Web of Science ®Google Scholar
• Starkweather A, Kelly DL, Thacker L, et al. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer. Support Care Cancer. 2017;25(1):167–176.
   PubMed Web of Science ®Google Scholar
• Wang XM, Walitt B, Saligan L, et al. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine. 2015;72(1):86–96.
   PubMed Web of Science ®Google Scholar
• Lyon D, Elmore L, Aboalela N, et al. Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis. Biol Res Nurs. 2014;16(2):160–174.
   PubMed Web of Science ®Google Scholar
• Smith AK, Conneely KN, Pace TW, et al. Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun. 2014;38:227–236.
   PubMed Web of Science ®Google Scholar
• Hon GC, Hawkins RD, Caballero OL, et al. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res. 2012;22(2):246–258.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang Y, Gu Y, et al. Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns. Mol Oncol. 2018;12(7):1047–1060.
   PubMed Web of Science ®Google Scholar
• Park SY, Kwon HJ, Lee HE, et al. Promoter CpG island hypermethylation during breast cancer progression. Virchows Arch. 2011;458(1):73–84.
   PubMed Web of Science ®Google Scholar
• Holm K, Staaf J, Lauss M, et al. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells. Breast Cancer Res. 2016;18(1):27.
   PubMedGoogle Scholar
• Flanagan JM, Wilson A, Koo C, et al. Platinum-based chemotherapy induces methylation changes in blood dna associated with overall survival in patients with ovarian cancer. Clin Cancer Res. 2017;23(9):2213–2222.
   PubMed Web of Science ®Google Scholar
• Flowers E, Flentje A, Levine J, et al. A pilot study using a multistaged integrated analysis of gene expression and methylation to evaluate mechanisms for evening fatigue in women who received chemotherapy for breast cancer. Biol Res Nurs. 2019;21(2):142–156.
   PubMed Web of Science ®Google Scholar
• Kovalchuk A, Ilnytskyy Y, Woycicki R, et al. Adverse effects of paternal chemotherapy exposure on the progeny brain: intergenerational chemobrain. Oncotarget. 2018;9(11):10069–10082.
   PubMedGoogle Scholar
• Mathews HL, Konley T, Kosik KL, et al. Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress. Brain Behav Immun. 2011;25(5):830–839.
   PubMed Web of Science ®Google Scholar
• Shnorhavorian M, Schwartz SM, Stansfeld B, et al. Differential DNA methylation regions in adult human sperm following adolescent chemotherapy: potential for epigenetic inheritance. PLoS One. 2017;12(2):e0170085.
   PubMed Web of Science ®Google Scholar
• Stephens KE, Levine JD, Aouizerat BE, et al. Associations between genetic and epigenetic variations in cytokine genes and mild persistent breast pain in women following breast cancer surgery. Cytokine. 2017;99:203–213.
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Longo DL. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018;378(14):1323–1334.
   PubMed Web of Science ®Google Scholar
• Haberman RP, Quigley CK, Gallagher M. Characterization of CpG island DNA methylation of impairment-related genes in a rat model of cognitive aging. Epigenetics. 2012;7(9):1008–1019.
   PubMed Web of Science ®Google Scholar
• Lyon DE, Cohen R, Chen H, et al. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol. 2016;301:74–82.
   PubMed Web of Science ®Google Scholar
• Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.
   PubMed Web of Science ®Google Scholar
• Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol. 2006;21(7):623–643.
   PubMed Web of Science ®Google Scholar
• Scherling C, Collins B, Mackenzie J, et al. Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Front Hum Neurosci. 2011;5:122.
   PubMed Web of Science ®Google Scholar
• Breckenridge LM, Bruns GL, Todd BL, et al. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psychooncology. 2012;21(1):43–53.
   PubMed Web of Science ®Google Scholar
• van Iterson M, Tobi EW, Slieker RC, et al. MethylAid: visual and interactive quality control of large Illumina 450k datasets. Bioinformatics. 2014;30(23):3435–3437.
   PubMed Web of Science ®Google Scholar
• Burnham KP, Anderson DR. Model selection and multimodel inference: A practical-theoretic approach. 2nd ed. New York: Springer-Verlag; 2002.
   Google Scholar
• Gantala SR, Kondapalli MS, Kummari R, et al. Collagenase-1 (−1607 1G/2G), gelatinase-A (−1306 C/T), stromelysin-1 (−1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy. Gene. 2018;673:22–31.
   PubMed Web of Science ®Google Scholar
• McLean CY, Bristor D, Hiller M, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol. 2010;28(5):495–501.
   PubMed Web of Science ®Google Scholar
• Keller TE, Han P, Yi SV. Evolutionary transition of promoter and gene body DNA methylation across invertebrate-vertebrate boundary. Mol Biol Evol. 2016;33(4):1019–1028.
   PubMed Web of Science ®Google Scholar
• Halder R, Hennion M, Vidal RO, et al. DNA methylation changes in plasticity genes accompany the formation and maintenance of memory. Nat Neurosci. 2016;19(1):102–110.
   PubMed Web of Science ®Google Scholar
• Sultan FA, Day JJ. Epigenetic mechanisms in memory and synaptic function. Epigenomics. 2011;3(2):157–181.
   PubMed Web of Science ®Google Scholar
• Myers JS. Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum. 2012;39(1):E31–E40.
   PubMedGoogle Scholar
• Rodriguiz RM, Gadnidze K, Ragnauth A, et al. Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory. Genes Brain Behav. 2008;7(4):418–426.
   PubMed Web of Science ®Google Scholar
• Pacheco-Quinto J, Eckman CB, Eckman EA. Major amyloid-β–degrading enzymes, endothelin-converting enzyme-2 and neprilysin, are expressed by distinct populations of GABAergic interneurons in hippocampus and neocortex. Neurobiol Aging. 2016;48:83–92.
   PubMed Web of Science ®Google Scholar
• Pacheco-Quinto J, Herdt A, Eckman CB, et al. Endothelin-converting enzymes and related metalloproteases in Alzheimer’s disease. J Alzheimers Dis. 2013;33(Suppl 1):S101–S110.
   PubMedGoogle Scholar
• Weeraratna AT, Kalehua A, Deleon I, et al. Alterations in immunological and neurological gene expression patterns in Alzheimer’s disease tissues. Exp Cell Res. 2007;313(3):450–461.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8(6):595–608.
   PubMed Web of Science ®Google Scholar
• Brock PR, Maibach R, Childs M, et al. Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med. 2018;378(25):2376–2385.
   PubMed Web of Science ®Google Scholar
• Frisina RD, Wheeler HE, Fossa SD, et al. Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol. 2016;34(23):2712–2720.
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, de Haro M, Hao S, et al. Reduction of Nuak1 decreases tau and reverses phenotypes in a Tauopathy Mouse Model. Neuron. 2016;92(2):407–418.
   PubMed Web of Science ®Google Scholar
• Aboalela N, Lyon D, Elswick RK Jr., et al. Perceived stress levels, chemotherapy, radiation treatment and tumor characteristics are associated with a persistent increased frequency of somatic chromosomal instability in women diagnosed with breast cancer: a one year longitudinal study. PLoS One. 2015;10(7):e0133380.
   PubMed Web of Science ®Google Scholar
• Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540–550.
   PubMed Web of Science ®Google Scholar
• Allavena P, Germano G, Marchesi F, et al. Chemokines in cancer related inflammation. Exp Cell Res. 2011;317(5):664–673.
   PubMed Web of Science ®Google Scholar
• Iwamoto T, Bianchini G, Booser D, et al. Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J Natl Cancer Inst. 2011;103(3):264–272.
   PubMed Web of Science ®Google Scholar
• Janelsins MC, Mustian KM, Palesh OG, et al. Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer. 2012;20(4):831–839.
   PubMed Web of Science ®Google Scholar
• Terrando N, Rei Fidalgo A, Vizcaychipi M, Cibelli M, Ma D, Monaco C, et al. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care. 2010;14(3):R88.
   PubMed Web of Science ®Google Scholar
• Hennessy E, Gormley S, Lopez-Rodriguez AB, et al. Systemic TNF-α produces acute cognitive dysfunction and exaggerated sickness behavior when superimposed upon progressive neurodegeneration. Brain Behav Immun. 2017;59:233–244.
   PubMed Web of Science ®Google Scholar
• Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130(2):223–233.
   PubMed Web of Science ®Google Scholar
• Te Poele RH, Okorokov AL, Jardine L, et al. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002;62(6):1876–1883.
   PubMed Web of Science ®Google Scholar
• Schur RR, Boks MP, Rutten BPF, et al. Longitudinal changes in glucocorticoid receptor exon 1F methylation and psychopathology after military deployment. Transl Psychiatry. 2017;7(7):e1181.
   PubMedGoogle Scholar
• Pang KKL, Sharma M, Sajikumar S. Epigenetics and memory: emerging role of histone lysine methyltransferase G9a/GLP complex as bidirectional regulator of synaptic plasticity. Neurobiol Learn Mem. 2019;159:1–5.
   PubMed Web of Science ®Google Scholar
• Ptak C, Petronis A. Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci. 2010;12(1):25–35.
   PubMedGoogle Scholar
• Sweatt JD. Neural plasticity and behavior - sixty years of conceptual advances. J Neurochem. 2016;139(Suppl 2):179–199.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Sportelli V, Ziller M, et al. Epigenomics of major depressive disorders and schizophrenia: early life decides. Int J Mol Sci. 2017;18:8.
   Web of Science ®Google Scholar
• Braun PR, Han S, Hing B, et al. Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals. Transl Psychiatry. 2019;9(1):47.
   PubMed Web of Science ®Google Scholar